These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4814803)

  • 41. Further observations on the nature and characteristics of cross protection against Fasciola hepatica produced in sheep by infection with Cysticercus tenuicollis.
    Dineen JK; Kelly JD; Campbell NJ
    Int J Parasitol; 1978 Jun; 8(3):173-6. PubMed ID: 748207
    [No Abstract]   [Full Text] [Related]  

  • 42. The early migratory behaviour of young Fasciola hepatica in sensitized mice.
    Harness E; Doy TG; Hughes DL
    Int J Parasitol; 1977 Feb; 7(1):51-4. PubMed ID: 858656
    [No Abstract]   [Full Text] [Related]  

  • 43. Isolation and labeling of Fasciola hepatica antigen active during the infection.
    Cuperlović K; Movsesijan M
    J Parasitol; 1972 Dec; 58(6):1209-10. PubMed ID: 4641895
    [No Abstract]   [Full Text] [Related]  

  • 44. Scanning electron microscopy of Fasciola hepatica L. during growth and maturation in the mouse.
    Bennett CE
    J Parasitol; 1975 Oct; 61(5):892-8. PubMed ID: 1185431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin hypersensitivity reactions induced in calves by experimental infections with Fasciola hepatica.
    Doyle JJ
    Int Arch Allergy Appl Immunol; 1973; 45(5):752-8. PubMed ID: 4270694
    [No Abstract]   [Full Text] [Related]  

  • 46. Early migration of immature Fasciola hepatica and associated liver pathology in cattle.
    Doy TG; Hughes DL
    Res Vet Sci; 1984 Sep; 37(2):219-22. PubMed ID: 6505402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EFficacy of albendazole for treatment of naturally acquired fasciola hepatica in calves.
    Malone JB; Smith PH; Loyacano AF; Hembry FG; Brock LT
    Am J Vet Res; 1982 May; 43(5):879-81. PubMed ID: 7091853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamics of host-parasite interactions: the example of population biology of the liver fluke (Fasciola hepatica).
    Hurtrez-Boussès S; Meunier C; Durand P; Renaud F
    Microbes Infect; 2001 Aug; 3(10):841-9. PubMed ID: 11580979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The experimental transfer of adult Fasciola hepatica between various mammalian hosts.
    Hughes DL; Harness E
    Res Vet Sci; 1972 Sep; 13(5):422-6. PubMed ID: 4635113
    [No Abstract]   [Full Text] [Related]  

  • 50. Development and pathology of Fasciola hepatica in CCL3-deficient mice.
    De Paula RC; Cassali GD; Negrão-Corrêa D; Guimarães MP
    Vet Parasitol; 2010 Oct; 173(1-2):147-51. PubMed ID: 20643506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica.
    Walker SM; Hoey E; Fletcher H; Brennan G; Fairweather I; Trudgett A
    Parasitology; 2006 Aug; 133(Pt 2):209-16. PubMed ID: 16597358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism.
    Serradell MC; Guasconi L; Cervi L; Chiapello LS; Masih DT
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):197-208. PubMed ID: 17449115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep.
    Zhang WY; Moreau E; Hope JC; Howard CJ; Huang WY; Chauvin A
    Exp Parasitol; 2005 Nov; 111(3):154-9. PubMed ID: 16126202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections.
    Oldham G
    Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fasciola hepatica: influence of thymus function on the liver pathology in mice.
    Eriksen L
    Nord Vet Med; 1980 Nov; 32(11):493-500. PubMed ID: 7232134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoexpression of intermediate filaments and morphological changes in the liver and bile duct of rats infected with Fasciola hepatica.
    Kolodziejczyk L; Laszczyńska M; Masiuk M; Grabowska M; Skrzydlewska E
    Biotech Histochem; 2015; 90(7):477-85. PubMed ID: 25923046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early and transient cytotoxic response of peritoneal cells from Fasciola hepatica-infected rats.
    Sibille P; Tliba O; Boulard C
    Vet Res; 2004; 35(5):573-84. PubMed ID: 15369660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the administration of a homologous antigen on the establishment of Fasciola hepatica in the rabbit.
    Sinclair IJ; Joyner LP
    Res Vet Sci; 1974 May; 16(3):320-327. PubMed ID: 4854782
    [No Abstract]   [Full Text] [Related]  

  • 60. Parenteral infection of laboratory animals with metacercariae of Fasciola hepatica.
    Movsesijan M; Cuperlović K
    Res Vet Sci; 1973 Mar; 14(2):265-6. PubMed ID: 4217919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.